iMeds.se

Detrusitol

Information för alternativet: Detrusitol 1 Mg Filmdragerad Tablett, Detrusitol 2 Mg Filmdragerad Tablett, visa andra alternativ
Document: Detrusitol film-coated tablet ENG PL change

PACKAGE LEAFLET: INFORMATION FOR THE USER


Detrusitol 1 mg & 2 mg film-coated tablets

Tolterodine


Read all of this leaflet carefully before you start using this medicine.



In this leaflet:


What Detrusitol is and what it is used for

Before you take Detrusitol

How to take Detrusitol

Possible side effects

How to store Detrusitol

Further information


1. What DETRUSITOL is and what it is used for


The active substance in Detrusitol is tolterodine. Tolterodine belongs to a class of medicinal products called antimuscarinics.

Detrusitol is used for the treatment of the symptoms of overactive bladder syndrome. If you have overactive bladder syndrome, you may find that:

2. Before you take DETRUSITOL


Do not take Detrusitol if you:



Take special care with DETRUSITOL


  • an abnormal heart tracing (ECG);

  • a slow heart rate (bradycardia);

  • relevant pre-existing cardiac diseases such as:

- cardiomyopathy (weak heart muscle)

- myocardial ischaemia (reduced blood flow to the heart)

- arrhythmia (irregular heartbeat)

- and heart failure

If you have abnormally low levels of potassium (hypokalaemia), calcium (hypocalcaemia) or magnesium (hypomagnesaemia) in your blood.


Talk to your doctor or pharmacist before starting your treatment with Detrusitol if you think any of these might apply to you.


Taking other medicines

Tolterodine, the active substance of Detrusitol, may interact with other medicinal products.


It is not recommended to use tolterodine in combination with:


Detrusitol should be used with caution when taken in combination with:


Please tell your doctor if you are taking or have recently taken any other medicines, including medicines obtained without a prescription.


Taking Detrusitol with food and drink

Detrusitol can be taken before, after or during a meal.


Pregnancy and breast-feeding

Pregnancy

You should not use Detrusitol when you are pregnant. Tell your doctor immediately if you are pregnant, think you are pregnant or are planning to become pregnant.


Breast-feeding

It is not known if tolterodine, the active substance of Detrusitol, is excreted in the mother’s breast milk. Breast-feeding is not recommended during administration of Detrusitol.


Ask your doctor or pharmacist for advice before taking any medicine.


Driving and using machines

Detrusitol may make you feel dizzy, tired or affect your sight; your ability to drive or operate machinery may be affected.


3. How to take DETRUSITOL


Dosage

Always take Detrusitol exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.


The usual dose is one 2 mg tablet twice daily, except for patients who have a kidney or a liver condition or troublesome side effects in which case your doctor may reduce your dose to one 1 mg tablet twice daily.


Detrusitol is not recommended for children.


The tablets are for oral use and should be swallowed whole.


Duration of treatment

Your doctor will tell you how long your treatment with Detrusitol will last. Do not stop treatment early because you do not see an immediate effect. Your bladder will need some time to adapt. Finish the course of tablets prescribed by your doctor. If you have not noticed any effect by then, talk to your doctor.


The benefit of the treatment should be re-evaluated after 2 or 3 months.


Always consult your doctor if you are thinking of stopping the treatment.


If you have taken more Detrusitol than you should:

If you or somebody else takes too many tablets, contact your doctor or pharmacist immediately.



If you forget to take Detrusitol

If you forget to take a dose at the usual time, take it as soon as you remember unless it is almost time for your next dose. In that case, omit the forgotten dose and follow the normal dose schedule.

Do not take a double dose to make up for a forgotten one.


If you have any further questions on the use of this product, ask your doctor or pharmacist.


4. Possible side effects


Like all medicines, Detrusitol can cause side effects, although not everybody gets them.


You should see your doctor immediately or go to the casualty department if you experience symptoms of angioedema such as


You should also seek medical attention if you experience a hypersensitivity reaction (for example itching, rash, hives, difficulty breathing). This occurs uncommonly (occurs in less than 1 in 100 patients).


Tell your doctor immediately or go to the casualty department if you notice any of the following:

chest pain, difficulty breathing or getting tired easily (even at rest), difficulty breathing at night, swelling of the legs.

These may be symptoms of heart failure. This occurs uncommonly (occurs in less than 1 in 100 patients).


The following side effects have been observed during treatment with Detrusitol with the following frequencies.


Very common side effects (occurs in more than 1 in 10 patients) are:


Common side effects (occurs in less than 1 in 10 patients) are:


Uncommon side effects (occurs in less than 1 in 100 patients) are:


Additional reactions reported include severe allergic reactions, confusion, hallucinations, flushed skin angioedema, and desorientation. There have also been reports of worsening symptoms of dementia in patients being treated for dementia.


If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.


5. How to store DETRUSITOL


Keep Detrusitol out of the reach and sight of children.


Do not use Detrusitol after the expiry date which is stated on the label/carton. The expiry date refers to the last day of that month.


No special precautions for storage.


Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.


6. Further information


What Detrusitol contains

The active substance in Detrusitol 1 mg tablets is 1 mg of tolterodine tartrate, equivalent to 0.68 mg of tolterodine.

The active substance in Detrusitol 2 mg tablets is 2 mg of tolterodine tartrate, equivalent to 1.37 mg of tolterodine.


The other ingredients are:

Core: Microcrystalline cellulose, calcium hydrogen phosphate dihydrate, sodium starch glycollate, magnesium stearate and colloidal anhydrous silica.


Film coating: Hypromellose, microcrystalline cellulose, stearic acid and titanium dioxide (E171).


What Detrusitol looks like and contents of the pack


Detrusitol 1 mg tablets are white, round, biconvex and marked with arcs above and below the lettering TO.

Detrusitol 2 mg tablets are white, round, biconvex and marked with arcs above and below the lettering DT.


Detrusitol 1 mg and 2 mg tablets are available in the following pack sizes:

Blister packs containing;


Bottles containing 60 or 500 tablets.

Please note that not all the above pack sizes may be marketed.


Marketing authorisation holder and manufacturer


Marketing authorisation holder:

Pfizer AB

191 90 Sollentuna

Sweden


Manufacturer:

Pfizer Italia S.r.l

Localita Marino del Tronto, 63100 Ascoli Piceno

Italy


This medicinal product is authorised in the following Member States of the EEA under the trade name Detrusitol:

Austria, Belgium, Luxembourg, Finland, France, Germany, Greece, Ireland, Italy, Netherlands, Portugal, Spain, Sweden & United Kingdom.


This leaflet was last approved in 2013-05-08